Skip to main navigation Skip to search Skip to main content

Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Analysis of longitudinally obtained HIV-1 env sequences from an individual with reported cross-reactive neutralizing activity revealed that the majority of viral variants obtained from serum between 4 and 7 years after seroconversion were unable to persist in peripheral blood. Here we show that these viral variants were more sensitive to autologous serum neutralization, had shorter envelopes with fewer potential N-linked glycosylation sites, and showed lower replication kinetics than successfully evolving HIV-1 variants. These data reflect the host selection pressures on phenotypic characteristics of HIV-1 and illustrate in detail the dynamic interaction between HIV-1 and its host's humoral immune responses
Original languageEnglish
Pages (from-to)8443-8448
JournalJournal of virology
Volume85
Issue number16
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum'. Together they form a unique fingerprint.

Cite this